Enmox Plus Eye Drop contains Moxifloxacin 0.5% w/v, a broad-spectrum fluoroquinolone antibiotic indicated for the treatment of bacterial infections of the eye. Moxifloxacin acts by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes essential for bacterial DNA replication, transcription, repair, and recombination, thereby exerting bactericidal activity against a wide range of gram-positive and gram-negative pathogens. Enmox Plus Eye Drop is primarily prescribed for bacterial conjunctivitis, keratitis, and other superficial ocular infections caused by susceptible organisms. The formulation ensures rapid penetration into ocular tissues, providing effective therapeutic concentrations at the site of infection. It is typically administered as one to two drops instilled into the affected eye(s) every two to four hours initially, followed by a reduced frequency as clinical improvement is observed, with treatment duration generally spanning 7 to 10 days. Patients should adhere strictly to the prescribed dosage regimen to prevent resistance development. Adverse effects are usually mild and transient, including ocular irritation, burning sensation, or dryness. Enmox Plus Eye Drop is contraindicated in individuals with known hypersensitivity to moxifloxacin or other quinolones. Proper hygiene should be maintained during application to avoid contamination. This medication should be used under medical supervision to ensure safety and efficacy.